Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12612000435886Phase 2Completed
Phase 2, randomised, single-blind trial of propofol in propofol injection site pain (PISP) (3 arms), sponsored by Serdar Koseoglu. Primary endpoint: Pain induced by propofol injection. Started Sep 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12612000435886.